Literature DB >> 35095338

Multigram Synthesis of Advanced 6,6-Difluorospiro[3.3]heptane-derived Building Blocks.

Oleksandr S Olifir1,2, Anton V Chernykh1, Alexey V Dobrydnev1,2, Oleksandr O Grygorenko1,2, Yuriy S Moroz2,3, Zoia V Voitenko2, Dmytro S Radchenko1.   

Abstract

A convenient methodology for constructing 6,6-difluorospiro[3.3]heptane scaffold - a conformationally restricted isostere of gem-difluorocycloalkanes - is developed. Alarge array of novel 2-mono- and 2,2-bifunctionalized difluorospiro[3.3]heptane building blocks was obtained through the convergent synthesis strategy using a common synthetic precursor - 1,1-bis(bromomethyl)-3,3-difluorocyclobutane. The target compounds and intermediates were prepared by short reaction sequences (6-10 steps) on multigram scale (up to 0.47 kg).

Entities:  

Keywords:  building blocks; cyclization; organofluorine compounds; small rings; spiro compounds

Year:  2020        PMID: 35095338      PMCID: PMC8791643          DOI: 10.1002/ejoc.202000432

Source DB:  PubMed          Journal:  European J Org Chem        ISSN: 1099-0690


  8 in total

Review 1.  Lead-oriented synthesis: a new opportunity for synthetic chemistry.

Authors:  Alan Nadin; Channa Hattotuwagama; Ian Churcher
Journal:  Angew Chem Int Ed Engl       Date:  2012-01-03       Impact factor: 15.336

Review 2.  The use of spirocyclic scaffolds in drug discovery.

Authors:  Yajun Zheng; Colin M Tice; Suresh B Singh
Journal:  Bioorg Med Chem Lett       Date:  2014-07-05       Impact factor: 2.823

Review 3.  Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.

Authors:  Nicholas A Meanwell
Journal:  Chem Res Toxicol       Date:  2016-03-14       Impact factor: 3.739

4.  Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.

Authors:  Patrick Dorr; Mike Westby; Susan Dobbs; Paul Griffin; Becky Irvine; Malcolm Macartney; Julie Mori; Graham Rickett; Caroline Smith-Burchnell; Carolyn Napier; Rob Webster; Duncan Armour; David Price; Blanda Stammen; Anthony Wood; Manos Perros
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Expanding the azaspiro[3.3]heptane family: synthesis of novel highly functionalized building blocks.

Authors:  Johannes A Burkhard; Carine Guérot; Henner Knust; Erick M Carreira
Journal:  Org Lett       Date:  2011-11-23       Impact factor: 6.005

6.  Synthesis and structural analysis of angular monoprotected diamines based on spiro[3.3]heptane scaffold.

Authors:  Anton V Chernykh; Dmytro S Radchenko; Oleksandr O Grygorenko; Constantin G Daniliuc; Dmitriy M Volochnyuk; Igor V Komarov
Journal:  J Org Chem       Date:  2015-03-25       Impact factor: 4.354

7.  Difluorophenylsulfanylmethyl radical and difluoromethylene diradical synthons: gem-difluoromethylene building block.

Authors:  Vichai Reutrakul; Thanchanok Thongpaisanwong; Patoomratana Tuchinda; Chutima Kuhakarn; Manat Pohmakotr
Journal:  J Org Chem       Date:  2004-10-01       Impact factor: 4.354

8.  Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.

Authors:  Janeta Popovici-Muller; René M Lemieux; Erin Artin; Jeffrey O Saunders; Francesco G Salituro; Jeremy Travins; Giovanni Cianchetta; Zhenwei Cai; Ding Zhou; Dawei Cui; Ping Chen; Kimberly Straley; Erica Tobin; Fang Wang; Muriel D David; Virginie Penard-Lacronique; Cyril Quivoron; Véronique Saada; Stéphane de Botton; Stefan Gross; Lenny Dang; Hua Yang; Luke Utley; Yue Chen; Hyeryun Kim; Shengfang Jin; Zhiwei Gu; Gui Yao; Zhiyong Luo; Xiaobing Lv; Cheng Fang; Liping Yan; Andrew Olaharski; Lee Silverman; Scott Biller; Shin-San M Su; Katharine Yen
Journal:  ACS Med Chem Lett       Date:  2018-01-19       Impact factor: 4.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.